Drug development is such a formidable challenge that, some believe, it can only be undertaken effectively by big pharma. Time-consuming and expensive, the classic approach has been to screen vast ...

Protein arrays are a relatively new technique for studying protein-protein interactions and profiling antibody binding and specificity, and in the past year a number of companies have released premade ...

Proteins, the natural molecules that carry out key cellular functions within the body, are the building blocks of all diseases. Characterizing proteins can reveal the mechanisms of a disease, ...

SINGAPORE--(BUSINESS WIRE)--Sengenics, a functional proteomics company, today announced the product launch of a new KREX™-based array, the ImmuKyne™ protein array, in a bid to enhance and accelerate ...

Protein microarrays are emerging as one of the most active areas in biotechnology today. Steady advances are overcoming initial skepticism as to their feasibility and utility. Industry sources project ...

Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

Scientists at Northwestern University have developed a new detection technology on the nanometer scale that could lead to the next generation of proteomic arrays and new methods for diagnosing ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More DeepMind and the European Bioinformatics Institute (EMBL), a life ...

Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Let the OSS Enterprise newsletter guide your open source journey! Sign up ...